Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane Plus Hormonal Therapy in Prostate Cancer
NCT00521781Phase 2Terminated
- Sponsor
- Houston Methodist Research Institute
- Start
- Aug 2007
- Primary completion
- Sep 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel in prostate adenocarcinoma, sponsored by Houston Methodist Research Institute. Primary endpoint: Time to Tumor Progression. Started Aug 2007; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT00521781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521781.